Related references
Note: Only part of the references are listed.High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
Minjie Huang et al.
DISEASE MARKERS (2015)
Systematic Review of Protein Biomarkers of Invasive Behavior in Glioblastoma
Eli T. Sayegh et al.
MOLECULAR NEUROBIOLOGY (2014)
The role of the PTEN gene in malignant gliomas
George A. Alexiou et al.
Neurologia i Neurochirurgia Polska (2014)
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
Jian Feng et al.
ONCOTARGET (2014)
SASH1 regulates melanocyte transepithelial migration through a novel Gαs-SASH1-IQGAP1-E-Cadherin dependent pathway
Ding'an Zhou et al.
CELLULAR SIGNALLING (2013)
SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell
Qingbing Meng et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Identification of FN1BP1 as a Novel Cell Cycle Regulator through Modulating G1 Checkpoint in Human Hepatocarcinoma Hep3B Cells
Mei Liu et al.
PLOS ONE (2013)
Effects of SASH1 on melanoma cell proliferation and apoptosis in vitro
Sheyu Lin et al.
MOLECULAR MEDICINE REPORTS (2012)
Effects of SASH1 on lung cancer cell proliferation, apoptosis, and invasion in vitro
En-guo Chen et al.
TUMOR BIOLOGY (2012)
Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells
Liu Yang et al.
TUMOR BIOLOGY (2012)
Protein Scaffolds Can Enhance the Bistability of Multisite Phosphorylation Systems
Carlo Chan et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
Adam Naguib et al.
BMC CANCER (2011)
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models
V. Marcel et al.
CELL DEATH AND DIFFERENTIATION (2011)
Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma
Jianfei Huang et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours
N. Rajan et al.
ONCOGENE (2011)
Chemokines and glioma: Invasion and more
Giuseppe Sciume et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas
M. Qu et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas
Y-J Kim et al.
JOURNAL OF PATHOLOGY (2008)
Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer
C. Rimkus et al.
BRITISH JOURNAL OF CANCER (2006)
Impaired immune responses and prolonged allograft survival in Sly1 mutant mice
S Beer et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades
YX Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold
D Chodniewicz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators
T Aviv et al.
NATURE STRUCTURAL BIOLOGY (2003)
SASH1:: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer
C Zeller et al.
ONCOGENE (2003)
SAM domains: uniform structure, diversity of function
CA Kim et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Share Paper
